Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -76,173 | -42,304 | -38,820 | -45,544 | -29,370 |
| Depreciation Amortization | 1,710 | 997 | 90 | 81 | 44 |
| Accounts receivable | -27,439 | -258 | 570 | -1,429 | 99 |
| Accounts payable and accrued liabilities | 7,369 | 2,127 | -1,481 | 4,745 | -60 |
| Other Working Capital | 8,420 | -2,338 | 1,419 | 3,664 | 553 |
| Other Operating Activity | 37,534 | 1,027 | 3,760 | -6,286 | 476 |
| Operating Cash Flow | $-48,579 | $-40,749 | $-34,462 | $-44,769 | $-28,258 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,200 | -6,394 | -2,107 | -34,923 | 24,592 |
| PPE Investments | -406 | -168 | -23 | -146 | -85 |
| Sale Of Investment | 7,925 | 11,761 | 7,517 | 17,522 | N/A |
| Purchase Sale Intangibles | -53,368 | -35 | -35 | -1,035 | -35 |
| Other Investing Activity | -53,368 | -35 | -35 | -1,035 | -35 |
| Investing Cash Flow | $-35,649 | $5,164 | $5,352 | $-18,582 | $24,472 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 78,061 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 23,919 | 36,305 | 42,263 | 25,653 | 36,017 |
| Other Financing Activity | -17,610 | -796 | -500 | 0 | 0 |
| Financing Cash Flow | $84,370 | $35,509 | $41,763 | $25,653 | $36,017 |
| Exchange Rate Effect | 130 | 94 | -103 | 367 | 39 |
| Beginning Cash Position | 29,023 | 29,005 | 16,455 | 53,786 | 21,516 |
| End Cash Position | 29,295 | 29,023 | 29,005 | 16,455 | 53,786 |
| Net Cash Flow | $272 | $18 | $12,550 | $-37,331 | $32,270 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,579 | -40,749 | -34,462 | -44,769 | -28,258 |
| Capital Expenditure | -406 | -168 | -23 | -146 | -85 |
| Free Cash Flow | -48,985 | -40,917 | -34,485 | -44,915 | -28,343 |